Doosan Mobility Innovation Signed the First Dealership Contract in Europe With FRP Technologies
14.7.2021 05:50:00 EEST | Business Wire | Press release
Doosan Mobility Innovation(DMI) is accelerating its plan to enter the European market with the first European dealer, FRP Advanced Technologies Aerospace & Defence, S.L(FRP Tech.).
FRP Tech., is a professional drone sales and service provider, supporting innovative drone solutions and platforms for civil and military sectors. In particular, FRP Tech. plans to provide the optimal solution using DMI hydrogen drone on oil & gas companies and military that requires long endurance.
With a new dealer, DMI will be able to provide product sales and services to European customers.
DMI CEO Lee Doo-soon said, “We are able to enter the European markets that possess high growth potential through collaboration with FRP Tech.” and “The hydrogen drone is highly compatible with Europe’s environmental policies and provides a long endurance solution. It is expected to be used in various fields.”
Additionally, Francisco Requena Paredes, CEO of FRP Tech., said, “DMI’s hydrogen drone can become a game changer in the commercial drone market with its flight time.” and “Hydrogen drones are highly likely to be used in various fields, from wind power plant inspections to public safety.”
Meanwhile, according to Teal Group, the European commercial drone market is expected to reach 760 million USD in 2021, and grow to about 1.8 billion dollar in 2025 as BVLOS flights are partially allowed with the unification of EU regulations.
About Doosan Mobility Innovation
Doosan Mobility Innovation creates the world's first commercialized hydrogen fuel cell system for drones, which have 2-hours of flight time four times than battery drones. With long endurance, DMI’s hydrogen drones are utilized in various industrial fields including utility inspection, delivery, environmental monitoring, and public safety. Based on this green technology, DMI successfully launched its products in USA, China and Korea in 2019 and will expand its business globally.
About FRP Advanced Technologies Aerospace & Defence, S.L
FRP is a consulting and engineering company that integrates for its clients Unmanned Aerial Systems (UAS) technology in the core of their business in order to add know-how in an eco-sustainable vision that introduces hydrogen as a fuel helping to eliminate the carbon footprint. FRP supports the clients for incorporating aerial platforms with specific ad-hoc engineering, payload integration and AI solutions providing innovation for civilian and military sectors.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210713006239/en/
Contact information
Doosan Mobility Innovation
Name: Jiwon Yeo
Phone Number: +82-10-2960-0532
Email: Jiwon.yeo@doosan.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TIMELAB Develops OEM/ODM Hair Straightener Reaching 200°C at All Three Measured Points in 15 Seconds17.9.2026 17:00:00 EEST | Press release
TIMELAB Co., Ltd., a Japanese beauty-appliance OEM/ODM provider, has developed a hair straightener for OEM/ODM customization for international hair care brands and professional markets. In testing at 230 V with a 260°C setting, all three measured plate locations reached at least 200°C after 15 seconds. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914187865/en/ Three-Point Plate Testing A European-market development unit with a maximum setting of 260°C was tested at 230 V. Fifteen seconds after power-on, readings at the front, center and rear were 212.5°C, 227.5°C and 200.0°C, respectively. From around 60 seconds onward, temperature differences among the three points narrowed, indicating a stable trend. Precision Temperature Control An NTC sensor inside the metal ceramic heater (MCH) detects temperature. A microcontroller (MCU) reads the signal and adjusts heater output. Upper and lower MCH heaters are controlled indepen
Earnix Brings Agentic AI to the Decisions That Drive Insurance Performance17.9.2026 16:09:00 EEST | Press release
Earnix today announced the introduction of Agent Hub, a curated catalog of insurance-specific AI agents and apps within Earnix AIOS — the AI Orchestration System powering Earnix’s pricing and rating, underwriting, and customer engagement solutions. Agent Hub brings agentic AI directly into these solutions, enabling more intelligent workflows and strengthening the high-stakes decisions that shape pricing, underwriting, customer engagement, growth, and profitability. In an increasingly turbulent insurance environment, the useful life of an insurance decision is getting shorter. Risk and market conditions are changing faster, making growth, profitability, and portfolio performance harder to manage. AI is increasing the speed and scope of what insurers can analyze, recommend, and increasingly act on — but as intelligence moves closer to action, the standard for governance, explainability, and accountability also rises. For insurers, that shift has direct implications for both financial per
Medisca Launches Global Peptide Division17.9.2026 16:07:00 EEST | Press release
Medisca today announced the launch of Medisca Peptides, a dedicated global division focused on expanding access to API-grade peptides and building an integrated peptide platform for pharmaceutical and personalized medicine markets worldwide. As the peptide landscape evolves, Medisca is proactively building the capabilities and infrastructure needed to support API-grade peptides within applicable regulatory frameworks. The launch represents a significant long-term commitment to peptides, including the expansion of Medisca’s portfolio, strategic manufacturing relationships, and the pharmaceutical infrastructure needed to support the category’s growth. It also signals Medisca’s ambition to become a leading force in the next generation of peptide innovation. For Medisca, the opportunity is familiar. More than 35 years ago, the company was founded to help close the gap between the pharmaceutical standards compounders needed and the quality ingredients they could readily access. Today, as pe
Elliptic Launches Its Decode Agent to Answer On-Chain Risk Questions and Shows Its Work17.9.2026 16:00:00 EEST | Press release
Elliptic, the global leader in on-chain risk, today launched Decode, an AI agent built on Elliptic’s intelligence platform. The Decode agent answers natural-language questions about cryptoasset addresses and their exposure in seconds, and returns the evidence behind every answer. Compliance and investigations teams need answers to questions nobody planned for. Getting them out of the data is now a specialist skill, so the questions wait for someone who has it, or go unasked. Meanwhile illicit actors move at machine speed, and agents are starting to sit on both sides of a payment. General-purpose AI assistants can produce an answer. They cannot show where it came from. A fluent response with nothing behind it cannot be put in front of a second-line reviewer, an auditor, or a regulator. “The market is full of AI that asks to be trusted. That is not good enough when someone asks how you reached a decision,” said Jackson Hull, CTO at Elliptic. “We published the Elliptic Standard last week
AMRA Medical Earns TIME’s Highest “Outstanding” Rating in World’s Top HealthTech Companies 202617.9.2026 15:51:00 EEST | Press release
The 2026 result builds on AMRA’s inclusion in the inaugural ranking in 2025, when the company received a “Very High” designation. Its advancement to the top category reflects continued progress in scientific excellence and technological innovation, as well as the expanding application of MRI-based biomarkers across research, drug development, and clinical care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260917956850/en/ “Being recognized by TIME and Statista for the second consecutive year and receiving the highest ‘Outstanding’ designation is a meaningful recognition of AMRA’s continued progress,” said Olof Dahlqvist Leinhard, CEO of AMRA Medical. “It reflects the dedication of our team and the strong scientific foundation behind our work. Our mission is to advance the understanding of health and disease through MRI-based biomarkers, and we are proud to see that work recognized on a global stage.” At AMRA, our work is c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom